PubMed Health⌕ Search

Biomedical subjects

D Albeck

Publications and source records attributed to D Albeck.

20 records · Page 2Linked to original sources

Peptidergic transmission in the brain. IV. Sex hormone dependence in the vasopressin/oxytocin system.

The medial amygdaloid nucleus (AME) synthesizes a peptide similar to arginine vasopressin and projects peptidergic fibers to the ipsilateral hippocampus in the male rat. In previous studies, we have shown that the peptide acts as a transmitter and, using in vitro and in vivo electrophysiology, we have characterized its mechanism of action. Previous anatomical work has shown that the peptidergic fibers are more dense in male rats than females and are obliterated entirely by castration. Here we report the results of our attempt to find an electrophysiological correlate of these anatomical findings. First, we show specific mediation by a vasopressin- or oxytocin-like peptide by use of a structural vasotocin antagonist. Then we show that castration obliterates the peptidergic signal in males. However, we were unable to find any sex difference that corresponded to the male/female disparity noted in the density of the peptidergic fibers. The strength, nature and stimulus-response characteristics were the same between males and females. Apart from a very subtle difference in the duration of the signal, no physiological correlate of the sexual dimorphism could be found with our techniques. We conclude that the neurophysiology partly complements the anatomy and biochemistry of this system.

Amygdala↗

Effects of osteogenic protein-1 (OP-1) treatment on fetal spinal cord transplants to the anterior chamber of the eye.

Spinal cord injury represents a serious medical problem, and leads to chronic conditions that cannot be reversed at present. It has been suggested that trophic factor treatment may reduce the extent of damage and restore damaged neurons following the injury. We have tested the effects of osteogenic protein-1 (OP-1, also known as BMP-7), a member of the transforming growth factor-beta superfamily of growth factors, on developing spinal cord motor neurons in an intraocular transplantation model. Embryonic day 13 or 18 spinal cord tissue was dissected, incubated with OP-1 or vehicle, and injected into the anterior chamber of the eye of adult rats. Injections of additional doses of OP-1 were performed weekly, and the overall growth of the grafted tissue was assessed noninvasively. Four to 6 weeks postgrafting, animals were sacrificed and the tissue was processed for immunohistochemistry using antibodies directed against choline acetyltransferase, neurofilament, and the dendritic marker MAP-II. We found that OP-1 treatment stimulated overall growth of spinal cord tissue when dissected from embryonic day 18, but not from embryonic day 13. OP-1 treatment increased cell size and extent of cholinergic markers in motor neurons from both embryonic stages. The neurons also appeared to have a more extensive dendritic network in OP-1-treated grafts compared to controls. These findings indicate that OP-1 treatment may reduce the extent of axotomy-induced cell death of motor neurons, at least in the developing spinal cord.

Animals↗